You are viewing the site in preview mode

Skip to main content

Table 2 Comparison of data requirement for generics versus similar biological medicinal products. BE: bioequivalence; PMS: postmarketing study.

From: Current Status of Biosimilar Growth Hormone

Classic generics Biosimilars
Manufacturing Chemical synthesis Genetically modified cell lines
  Simple microbial fermentation Complex fermentation process
  Standard analytics Complex purification process
   Formulation
   Complex analytical characterization
Preclinic Generally none In vitro/in vivo bioassay
   Toxicity studies
   Local tolerance studies
   PK/PD studies
Clinic Generally BE study Phase I PK/PD
   Phase III studies
   Phase IIIb studies
   Phase IV studes (PMS)